| CATEGORY: AIM BULLETIN SECTOR: HEALTH CARE EQUIPMENT & SERVICES |
Cryo-Save hails French stem cell plans |
|
Thu 10 Dec 2009
|
LONDON (SHARECAST) - Adult stem cell storage bank operator Cryo-Save has, not surprisingly, welcomed the proposed new legislation in France supporting the collection and preservation of umbilical cord blood stem cells.
Under the proposals, pregnant women will be informed during pre-natal exams about cord blood stem cells and their therapeutic indicators.
The expectant mothers will be given the option to donate these stem cells for therapeutic or scientific use, or to store them for a a potential autologous or allogenic therapeutic use..
The legislation also propoes that all mothers should be allowed to have their umbilical cord blood stem cells collected, processed and stored by public or private entities.
Traditionally, France has preferred stem cell storage to be handled by organisations in the public sector but Arnoud van Tulder, Cryo-Save’s chief financial officer told Sharecast earlier this year that his company had invested a lot of time and money convincing the French authorities that it should be allowed to operate in the country alongside publicly owned stem cell laboratories.
‘France has the highest birth rate in Europe, so it is an important growth market for us,’ van Tulder told Sharecast.
Referring to the proposed new legislation, Marc Waeterschoot of the Dutch company said it would be ‘very important in helping to create awareness in France of cord blood banking and will significantly contribute to the development of our operations in the country which, with 850,000 births per year, has the potential to become the largest cord blood market in Europe.’
|
|
| |
|
 |
Archived Stories |
 |
|
Front Page Stories |
|
|
